EP0929575A4 - NEW HUMAN GROWTH FACTORS - Google Patents

NEW HUMAN GROWTH FACTORS

Info

Publication number
EP0929575A4
EP0929575A4 EP97924803A EP97924803A EP0929575A4 EP 0929575 A4 EP0929575 A4 EP 0929575A4 EP 97924803 A EP97924803 A EP 97924803A EP 97924803 A EP97924803 A EP 97924803A EP 0929575 A4 EP0929575 A4 EP 0929575A4
Authority
EP
European Patent Office
Prior art keywords
growth factors
human growth
new human
new
factors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP97924803A
Other languages
German (de)
French (fr)
Other versions
EP0929575A1 (en
Inventor
Guo-Liang Yu
Patrick J Dillon
Reinhard Ebner
Gregory A Endress
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Human Genome Sciences Inc
Original Assignee
Human Genome Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Human Genome Sciences Inc filed Critical Human Genome Sciences Inc
Publication of EP0929575A1 publication Critical patent/EP0929575A1/en
Publication of EP0929575A4 publication Critical patent/EP0929575A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/026—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a baculovirus

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
EP97924803A 1996-08-23 1997-08-22 NEW HUMAN GROWTH FACTORS Withdrawn EP0929575A4 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
WOPCT/US96/13766 1996-08-23
US9613766 1996-08-23
PCT/US1997/014139 WO1998007749A1 (en) 1996-08-23 1997-08-22 Novel human growth factors

Publications (2)

Publication Number Publication Date
EP0929575A1 EP0929575A1 (en) 1999-07-21
EP0929575A4 true EP0929575A4 (en) 2004-09-08

Family

ID=22255670

Family Applications (1)

Application Number Title Priority Date Filing Date
EP97924803A Withdrawn EP0929575A4 (en) 1996-08-23 1997-08-22 NEW HUMAN GROWTH FACTORS

Country Status (4)

Country Link
EP (1) EP0929575A4 (en)
JP (1) JP2002508652A (en)
AU (1) AU3011497A (en)
WO (1) WO1998007749A1 (en)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2292843A1 (en) * 1997-07-07 1999-01-21 Abbott Laboratories Reagents and methods useful for detecting diseases of the breast
NZ520967A (en) * 2000-02-25 2004-04-30 Oxford Glycosciences Uk Ltd Use of breast cancer associated membrane proteins (BCMP) for treatment, prophylaxis and diagnosis of breast cancer
AU2005218046B2 (en) * 2000-02-25 2008-07-03 Ucb Pharma S.A. Use of breast cancer associated membrane proteins (BCMP) for treatment, prophylaxis and diagnosis of breast cancer
US20040141974A1 (en) * 2000-02-25 2004-07-22 Boyd Robert Simon Diagnostic and therapeutic methods
GB0004576D0 (en) * 2000-02-25 2000-04-19 Oxford Glycosciences Uk Ltd Proteins
US20020015956A1 (en) * 2000-04-28 2002-02-07 James Lillie Compositions and methods for the identification, assessment, prevention, and therapy of human cancers
EP1666594A3 (en) * 2000-06-02 2006-06-21 Genentech, Inc. Polypeptide, nucleic acid encoding it, and their use for the diagnosis of cancer
RU2166957C1 (en) * 2000-10-09 2001-05-20 Санкт-Петербургская Общественная Организация "Санкт-Петербургский Институт Биорегуляции И Геронтологии Сзо Рамн" Tetrapeptide stimulating functional activity of hepatocytes, pharmacological agent based on thereof and method of its use
GB0222787D0 (en) * 2002-10-02 2002-11-06 Univ Liverpool Metastasis inducing compounds
JP2004298112A (en) * 2003-03-31 2004-10-28 Japan Science & Technology Agency Human solid tumor antigen peptide, polynucleotide encoding the same, and use thereof
GB0307918D0 (en) 2003-04-05 2003-05-14 Astrazeneca Ab Therapeutic use
ES2299281B1 (en) * 2003-10-22 2009-04-16 Progenika Biopharma, S.A. METHODS FOR IN VITRO AND FORECAST IN VITRO DIAGNOSIS OF THE CANCER OF PANCREAS, AND FOR THE DEVELOPMENT OF PHARMACOS AGAINST CANCER OF PANCREAS.
JP2007520217A (en) * 2004-01-27 2007-07-26 コンピュゲン ユーエスエイ，インク． Novel nucleotide and amino acid sequences, and assays and methods of use for breast cancer diagnosis using the same
EP2078203A1 (en) * 2006-08-29 2009-07-15 Oxford Genome Sciences (UK) Limited Protein
WO2008104803A2 (en) * 2007-02-26 2008-09-04 Oxford Genome Sciences (Uk) Limited Proteins
ES2552657T3 (en) 2010-05-26 2015-12-01 Satiogen Pharmaceuticals, Inc. Inhibitors of the recycling of bile acids and satiogens for the treatment of diabetes, obesity, and inflammatory gastrointestinal conditions
AU2012328526B2 (en) 2011-10-28 2017-05-25 Shire Human Genetic Therapies, Inc. Bile acid recycling inhibitors for treatment of pediatric cholestatic liver diseases
US20130108573A1 (en) 2011-10-28 2013-05-02 Lumena Pharmaceuticals, Inc. Bile Acid Recycling Inhibitors for Treatment of Hypercholemia and Cholestatic Liver Disease
AU2014229050A1 (en) 2013-03-15 2015-10-22 Lumena Pharmaceuticals Llc Bile acid recycling inhibitors for treatment of Barrett's esophagus and gastroesophageal reflux disease
CA2907230A1 (en) 2013-03-15 2014-09-18 Lumena Pharmaceuticals, Inc. Bile acid recycling inhibitors for treatment of primary sclerosing cholangitis and inflammatory bowel disease
EP3923943B1 (en) 2019-02-12 2024-07-31 Mirum Pharmaceuticals, Inc. Genotype and dose-dependent response to an asbti in patients with bile salt export pump deficiency

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998011217A2 (en) * 1996-09-13 1998-03-19 Sagami Chemical Research Center HUMAN PROTEINS HAVING SECRETORY SIGNAL SEQUENCES AND DNAs ENCODING THESE PROTEINS
WO1998041627A1 (en) * 1997-03-19 1998-09-24 Zymogenetics, Inc. Secreted polypeptides with homology to xenopus cement gland proteins
WO1999006548A2 (en) * 1997-08-01 1999-02-11 Genset 5'ESTs FOR NON TISSUE SPECIFIC SECRETED PROTEINS

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998011217A2 (en) * 1996-09-13 1998-03-19 Sagami Chemical Research Center HUMAN PROTEINS HAVING SECRETORY SIGNAL SEQUENCES AND DNAs ENCODING THESE PROTEINS
WO1998041627A1 (en) * 1997-03-19 1998-09-24 Zymogenetics, Inc. Secreted polypeptides with homology to xenopus cement gland proteins
WO1999006548A2 (en) * 1997-08-01 1999-02-11 Genset 5'ESTs FOR NON TISSUE SPECIFIC SECRETED PROTEINS

Non-Patent Citations (8)

* Cited by examiner, † Cited by third party
Title
DATABASE EMBL, HEIDELBERG, FRG [online] 1 January 1998 (1998-01-01), SIVE, H. ET AL.: "Cement gland-specific", XP002275165, Database accession no. O42251 *
DATABASE EMBL, HEIDELBERG, FRG [online] 17 June 1999 (1999-06-17), "Human 5' EST secreted protein SEQ ID NO: 343", XP002275164, Database accession no. AAY12312 *
DATABASE EMBL, HEIDELBERG, FRG [online] 17 June 1999 (1999-06-17), "Human secreted protein 5' EST SEQ ID NO: 89", XP002275183, Database accession no. AAX41145 *
DATABASE EMBL, HEIDELBERG, FRG [online] 5 December 1996 (1996-12-05), SIVE, H. ET AL.: "Xenopus laevis putative secreted protein XAG (XAG) mRNA, complete cds", XP002275163, Database accession no. U76752 *
DATABASE EMBL, HEIDELBERG,FRG [online] 9 September 1994 (1994-09-09), FRIGERIO, J.M. ET AL.: "EST050 Human colorectal cancer Homo sapiens cDNA clone 2B10, mRNA sequence", XP002275162, Database accession no. T24475 *
See also references of WO9807749A1 *
SIVE, H. & BRADLEY, L.: "A Sticky Problem: The Xenopus Cement Gland as a Paradigm for Anteroposterior Patterning", DEVELOPMENTAL DYNAMICS, vol. 205, no. 3, March 1996 (1996-03-01), pages 265 - 280, XP002072379 *
THOMPSON, D.A. & WEIGEL, R.J.: "hAG-2, the Human Homologue of the Xenopus laevis Cement Gland Gene XAG-2, Is Coexpressed with Estrogen Receptor in Breast Cancer Cell Lines", BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, vol. 251, no. 1, 9 October 1998 (1998-10-09), pages 111 - 116, XP001009725 *

Also Published As

Publication number Publication date
AU3011497A (en) 1998-03-06
JP2002508652A (en) 2002-03-19
EP0929575A1 (en) 1999-07-21
WO1998007749A1 (en) 1998-02-26

Similar Documents

Publication Publication Date Title
EP0871705A4 (en) HUMAN CCN-LIKE GROWTH FACTOR
DE59710859D1 (en) implant
DE69726608D1 (en) SCREWABLE IMPLANT
NO982991D0 (en) Growth hormone-sekretagoguer
BR9701466A (en) Area implant
EP0929575A4 (en) NEW HUMAN GROWTH FACTORS
FR2751867B1 (en) PROSTHESIS COLLERETTE
DE69735996D1 (en) HUMAN BIKININE
DE59706733D1 (en) harvester
DE69735754D1 (en) IMPEDANCE-DEPENDABLE IMPLANTABLE CARDIOVA DEFRIBILLATOR
DE59705517D1 (en) Harvester
DE59706164D1 (en) Harvester
FR2749162B1 (en) COTYLOIDIAN PROSTHESIS
DE69704693D1 (en) Harvester
KR970000015A (en) Growing artificial artificial skin procedure
ID16051A (en) INCREASED CHICKEN GROWTH
KR980000026U (en) Flowerpot
FR2756702B1 (en) PARASOL PLANTERS
DE69636232D1 (en) GROWTH FACTOR HTTER36
KR960035968U (en) bobber
KR970053464U (en) Tissue hanger
KR970056470U (en) bobber
KR960033169U (en) Flowerpot
BR7601137U (en) Bone
ATE328892T1 (en) GROWTH FACTOR HTTER36

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19990323

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

RIC1 Information provided on ipc code assigned before grant

Ipc: 7A 61P 35/00 B

Ipc: 7A 61K 48/00 B

Ipc: 7A 61K 39/395 B

Ipc: 7A 61K 38/18 B

Ipc: 7G 01N 33/53 B

Ipc: 7G 01N 33/50 B

Ipc: 7C 12Q 1/68 B

Ipc: 7C 07K 16/18 B

Ipc: 7C 07K 14/475 B

Ipc: 7C 12N 15/12 A

A4 Supplementary search report drawn up and despatched

Effective date: 20040721

17Q First examination report despatched

Effective date: 20060828

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20070301